Moiseev SV - Search Results

1

Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.

Nabatchikova EA, Abdurakhmanov DT, Rozina TP, Nikulkina EN, Tanaschuk EL, Moiseev SV. Nabatchikova EA, et al. Among authors: moiseev sv. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101714. doi: 10.1016/j.clinre.2021.101714. Epub 2021 Apr 27. Clin Res Hepatol Gastroenterol. 2021. PMID: 33930587

2

Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Abdurakhmanov DT, Rozina TP, Nikulkina EN, Nabatchikova EA, Chulanov VP, Moiseev SV. Abdurakhmanov DT, et al. Among authors: moiseev sv. Antivir Ther. 2018;23(8):705-708. doi: 10.3851/IMP3266. Antivir Ther. 2018. PMID: 30265242

3

Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Abdurakhmanov DT, Rozina TP, Nikulkina EN, Nabatchikova EA, Chulanov VP, Moiseev SV. Abdurakhmanov DT, et al. Among authors: moiseev sv. Antivir Ther. 2018;23(8):713. doi: 10.3851/IMP3273. Antivir Ther. 2018. PMID: 30681414 No abstract available.

4

Interstitial Lung Disease in Primary Biliary Cholangitis: A Cohort Prospective Study.

Kalashnikov M, Akulkina L, Brovko M, Sholomova V, Yanakaeva A, Abdurakhmanov D, Moiseev S. Kalashnikov M, et al. Life (Basel). 2023 Feb 2;13(2):416. doi: 10.3390/life13020416. Life (Basel). 2023. PMID: 36836775 Free PMC article.

5

Acute Kidney Injury in Hospitalized Patients with COVID-19: Risk Factors and Serum Biomarkers.

Shchepalina A, Chebotareva N, Akulkina L, Brovko M, Sholomova V, Androsova T, Korotchaeva Y, Kalmykova D, Tanaschuk E, Taranova M, Lebedeva M, Beketov V, Moiseev S. Shchepalina A, et al. Biomedicines. 2023 Apr 23;11(5):1246. doi: 10.3390/biomedicines11051246. Biomedicines. 2023. PMID: 37238917 Free PMC article.

6

Letter: cure of chronic hepatitis B and D after 12 years of treatment with low-dose standard interferon alfa-2b.

Burnevich E, Moiseev S, Mukhin N. Burnevich E, et al. Aliment Pharmacol Ther. 2016 Sep;44(6):649-50. doi: 10.1111/apt.13705. Aliment Pharmacol Ther. 2016. PMID: 27511138 Free article. No abstract available.

7

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.

Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine T; ProDERM investigators. Aggarwal R, et al. Arthritis Res Ther. 2024 Jan 17;26(1):27. doi: 10.1186/s13075-023-03232-2. Arthritis Res Ther. 2024. PMID: 38233885 Free PMC article. Clinical Trial.

8

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network. Elhai M, et al. Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9. Ann Rheum Dis. 2019. PMID: 30967395

9

Preliminary study of anti-CD40 and ubiquitin proteasome antibodies in primary podocytopaties.

Chebotareva N, Cao V, Vinogradov A, Alentov I, Sergeeva N, Kononikhin A, Moiseev S. Chebotareva N, et al. Front Med (Lausanne). 2023 Jun 20;10:1189017. doi: 10.3389/fmed.2023.1189017. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37409273 Free PMC article.

10

Tixagevimab/cilgavimab in ANCA-associated vasculitis: a prospective observational study.

Litvinova M, Bulanov N, Novikov P, Moiseev S. Litvinova M, et al. Clin Exp Rheumatol. 2024 Apr;42(4):937. doi: 10.55563/clinexprheumatol/xexruk. Epub 2023 Oct 23. Clin Exp Rheumatol. 2024. PMID: 37877380 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page